Glove Guard LP is committed to providing quality products that meet the basic need of keeping up with required personal protective equipment. Located in Highlands, TX, USA, some of the Limited Partners have been with the Glove Guard® product since its inception. Glove Guard LP was founded in August, 1999 and maintains a strong commitment to manufacture products that consider the full scope of return on investment for the ultimate consumer.
It has been our policy to listen to the concerns of the people using the products and then respond by providing simple tools that work. Glove Guard's line of products has withstoood the test of time by providing several aspects of bottom line savings while keeping the safety of the worker in mind. All products undergo inspection and testing to ensure compliance with our own high standards of integrity and quality.
All of the products carry replacement guarantees if they break while doing their job. Glove Guard LP has a dedicated staff of personnel who genuinely care and are ready to assist both direct and indirect customers. We manufacture products but aim to never lose sight of people.
Personal protective equipment
Personal protective equipment for Ebola
Due to the urgency of the Ebola outbreak and the WHO’s scale up of international response in west Africa, WHO is providing technical information on appropriate available essential medical devices which are indispensable for treatment centres, community-based units and other preventive activities, in affected and neighbouring countries.
Personal Protective Equipment (PPE) is most important in preventing transmission of the Ebola virus not only in treatment centres but also various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak.
On the 31 October 2014, WHO updated the Rapid Advice Guideline for Personal Protective Equipment for Ebola response and the technical specifications of the referred equipments, which can be downloaded below:
- Personal protective equipment in the context of filovirus disease outbreak response
Rapid advice guideline October 2014 - Field situation: How to conduct safe and dignified burial of a patient who has died from suspected or confirmed Ebola virus disease
Innovative Personal Protective Equipment Survey
In order to understand personal protective equipment challenges and to inform innovation related to PPE, if you are a healthcare worker, logistician or procurement specialist with experience in PPE and EVD relief efforts, we kindly request your participation in an online survey found below. Collected responses will serve as a baseline assessment of the global use of PPE for healthcare service delivery in the context of Ebola virus disease (EVD). Please share this link with colleagues who have experience with PPE and EVD relief efforts. Responses will remain anonymous but you may choose to provide contact information should the results from this survey be of interest to you.
Available product
N 95 mask
3pl mask
Senetizer
PPE kit
PPE Kit available on Government price contact me on on 8929149265
Coronavirus disease 2019 (COVID-19), caused by the COVID-19 virus, was first detected in Wuhan, China, in December 2019. On 30 January 2020, the
WHO Director-General declared that the current outbreak constituted a public health emergency of international concern.
ThisdocumentsummarizesWHO’srecommendationsforthe rational use of personal protective equipment (PPE) in healthcare and community settings, as well as during the handling of cargo; in this context, PPE includes gloves, medical masks, goggles or a face shield, and gowns, as well asfor specific procedures, respirators (i.e., N95 or FFP2 standard or equivalent) and aprons. This document is intended for those who are involved in distributing and managing PPE, as well as public health authorities and individualsinhealthcareandcommunitysettings,anditaims to provide information about when PPE use is most appropriate.
WHOwillcontinuetoupdatetheserecommendationsasnew information becomesavailable.
Preventive measures for COVID-19 disease
Based on the available evidence, the COVID-19 virus is transmitted between people through close contact and droplets, not by airborne transmission. The people most at risk of infection are those who are in close contact with a COVID-19 patient or who care for COVID-19 patients.
Preventiveandmitigationmeasuresarekeyinbothhealthcare and community settings. The most effective preventive measures in the communityinclude:
performing hand hygiene frequently with an alcohol-basedhandrubifyourhandsarenot visibly dirty or with soap and water if hands aredirty;
avoiding touching your eyes, nose andmouth;
practicing respiratory hygiene by coughingor sneezing into a bent elbow or tissue and then immediately disposing of thetissue;
wearing a medical mask if you haverespiratory symptoms and performing hand hygiene after disposing of themask;
maintaining social distance (a minimum of 1m) from individuals with respiratorysymptoms.
Additional precautions are required by healthcare workersto protectthemselvesandpreventtransmissioninthehealthcare setting.Precautionstobeimplementedbyhealthcareworkers caring for patients with COVID-19 disease includeusing
PPEappropriately;thisinvolvesselectingtheproperPPEand being trained in how to put on, remove and dispose ofit.
PPE is only one effective measure within a package that comprisesadministrativeandenvironmentalandengineering controls, as described in WHO’s Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care (1). These controls are summarized here.
Administrative controls include ensuring the availability of resources for infection prevention and control measures, such as appropriate infrastructure, the development ofclear infection prevention and control policies, facilitated access to laboratory testing, appropriate triage and placement of patients, adequate staff-to-patient ratios and training ofstaff.
Environmental and engineering controls aim at reducing the spread of pathogens and reducing the contamination of surfaces and inanimate objects. They includeprovidingadequatespacetoallowsocialdistance of at least 1 m to be maintained between patients and between patients and healthcare workers and ensuring the availability of well-ventilated isolation rooms for patientswithsuspectedorconfirmedCOVID-19disease.
COVID-19 is a respiratory disease that is different from Ebola virus disease, which is transmitted through infected bodily fluids. Due to these differences in transmission, the PPE requirements for COVID-19 are different from those required for Ebola virus disease. Specifically, coveralls (sometimes called Ebola PPE) are not required when managing COVID-19 patients.
Coronavirus disease 2019 (COVID-19), caused by the COVID-19 virus, was first detected in Wuhan, China, in December 2019. On 30 January 2020, the
WHO Director-General declared that the current outbreak constituted a public health emergency of international concern.
ThisdocumentsummarizesWHO’srecommendationsforthe rational use of personal protective equipment (PPE) in healthcare and community settings, as well as during the handling of cargo; in this context, PPE includes gloves, medical masks, goggles or a face shield, and gowns, as well asfor specific procedures, respirators (i.e., N95 or FFP2 standard or equivalent) and aprons. This document is intended for those who are involved in distributing and managing PPE, as well as public health authorities and individualsinhealthcareandcommunitysettings,anditaims to provide information about when PPE use is most appropriate.
WHOwillcontinuetoupdatetheserecommendationsasnew information becomesavailable.
Preventive measures for COVID-19 disease
Based on the available evidence, the COVID-19 virus is transmitted between people through close contact and droplets, not by airborne transmission. The people most at risk of infection are those who are in close contact with a COVID-19 patient or who care for COVID-19 patients.
Preventiveandmitigationmeasuresarekeyinbothhealthcare and community settings. The most effective preventive measures in the communityinclude:
performing hand hygiene frequently with an alcohol-basedhandrubifyourhandsarenot visibly dirty or with soap and water if hands aredirty;
avoiding touching your eyes, nose andmouth;
practicing respiratory hygiene by coughingor sneezing into a bent elbow or tissue and then immediately disposing of thetissue;
wearing a medical mask if you haverespiratory symptoms and performing hand hygiene after disposing of themask;
maintaining social distance (a minimum of 1m) from individuals with respiratorysymptoms.
Additional precautions are required by healthcare workersto protectthemselvesandpreventtransmissioninthehealthcare setting.Precautionstobeimplementedbyhealthcareworkers caring for patients with COVID-19 disease includeusing
PPEappropriately;thisinvolvesselectingtheproperPPEand being trained in how to put on, remove and dispose ofit.
PPE is only one effective measure within a package that comprisesadministrativeandenvironmentalandengineering controls, as described in WHO’s Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care (1). These controls are summarized here.
Administrative controls include ensuring the availability of resources for infection prevention and control measures, such as appropriate infrastructure, the development ofclear infection prevention and control policies, facilitated access to laboratory testing, appropriate triage and placement of patients, adequate staff-to-patient ratios and training ofstaff.
Environmental and engineering controls aim at reducing the spread of pathogens and reducing the contamination of surfaces and inanimate objects. They includeprovidingadequatespacetoallowsocialdistance of at least 1 m to be maintained between patients and between patients and healthcare workers and ensuring the availability of well-ventilated isolation rooms for patientswithsuspectedorconfirmedCOVID-19disease.
COVID-19 is a respiratory disease that is different from Ebola virus disease, which is transmitted through infected bodily fluids. Due to these differences in transmission, the PPE requirements for COVID-19 are different from those required for Ebola virus disease. Specifically, coveralls (sometimes called Ebola PPE) are not required when managing COVID-19 patients.
No comments:
Post a Comment